JP2008230982A - Foamable aerosol composition - Google Patents
Foamable aerosol composition Download PDFInfo
- Publication number
- JP2008230982A JP2008230982A JP2007069251A JP2007069251A JP2008230982A JP 2008230982 A JP2008230982 A JP 2008230982A JP 2007069251 A JP2007069251 A JP 2007069251A JP 2007069251 A JP2007069251 A JP 2007069251A JP 2008230982 A JP2008230982 A JP 2008230982A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- foam
- aerosol composition
- stock solution
- aqueous stock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 239000011550 stock solution Substances 0.000 claims abstract description 46
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims abstract description 35
- 238000009835 boiling Methods 0.000 claims abstract description 27
- 239000004094 surface-active agent Substances 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims description 31
- 239000006260 foam Substances 0.000 abstract description 67
- 238000005187 foaming Methods 0.000 abstract description 28
- 239000000243 solution Substances 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 description 23
- -1 sucrose fatty acid esters Chemical class 0.000 description 23
- 235000014113 dietary fatty acids Nutrition 0.000 description 22
- 229930195729 fatty acid Natural products 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 13
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 12
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- 239000003915 liquefied petroleum gas Substances 0.000 description 11
- 150000001298 alcohols Chemical class 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 8
- OKIYQFLILPKULA-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxybutane Chemical compound COC(F)(F)C(F)(F)C(F)(F)C(F)(F)F OKIYQFLILPKULA-UHFFFAOYSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 229940104873 methyl perfluorobutyl ether Drugs 0.000 description 7
- 239000001294 propane Substances 0.000 description 7
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 239000003240 coconut oil Substances 0.000 description 6
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000004088 foaming agent Substances 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 239000001282 iso-butane Substances 0.000 description 6
- 229920003169 water-soluble polymer Polymers 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 229920006037 cross link polymer Polymers 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 229940083542 sodium Drugs 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- DFUYAWQUODQGFF-UHFFFAOYSA-N 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane Chemical compound CCOC(F)(F)C(F)(F)C(F)(F)C(F)(F)F DFUYAWQUODQGFF-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- GGZKJFGVSZKFLD-UHFFFAOYSA-N 1-prop-1-enyl-1h-imidazol-1-ium;chloride Chemical compound [Cl-].CC=CN1C=C[NH+]=C1 GGZKJFGVSZKFLD-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- QHKGDMNPQAZMKD-UHFFFAOYSA-N 2-amino-2-methylbutan-1-ol Chemical compound CCC(C)(N)CO QHKGDMNPQAZMKD-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- BDHGFCVQWMDIQX-UHFFFAOYSA-O 3-ethenyl-2-methyl-1h-imidazol-3-ium Chemical compound CC=1NC=C[N+]=1C=C BDHGFCVQWMDIQX-UHFFFAOYSA-O 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 244000086363 Pterocarpus indicus Species 0.000 description 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ONAIRGOTKJCYEY-UHFFFAOYSA-N Sucrose monostearate Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(CO)O1 ONAIRGOTKJCYEY-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- QDOYVNVYDMSCNN-UHFFFAOYSA-N benzoyl 3-(diethylamino)-2-hydroxybenzoate Chemical compound CCN(CC)C1=CC=CC(C(=O)OC(=O)C=2C=CC=CC=2)=C1O QDOYVNVYDMSCNN-UHFFFAOYSA-N 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- ZFDPAZDODACYOG-UHFFFAOYSA-M sodium;[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]methanesulfonate Chemical compound [Na+].CN1C(C)=C(NCS([O-])(=O)=O)C(=O)N1C1=CC=CC=C1 ZFDPAZDODACYOG-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、発泡性エアゾール組成物に関する。詳細には、泡状で吐出することができ、泡を指などで塗り伸ばすと徐々に起泡するものであり、また泡状で吐出するため吐出部材の通路内に残る量が少なく、アフタードローを抑制できる発泡性エアゾール組成物に関する。 The present invention relates to a foamable aerosol composition. Specifically, it can be discharged in the form of foam, and when the foam is spread with a finger or the like, the foam gradually rises, and since it is discharged in the form of foam, the amount remaining in the passage of the discharge member is small, and the after-draw The present invention relates to a foamable aerosol composition capable of suppressing the above.
従来、シェービングフォーム等のエアゾール組成物として、水性原液および液化ガスからなる発泡性エアゾール組成物が種々開発されている。これらの発泡性エアゾール組成物としては、ゲル状の状態で吐出され、ゲルを指で塗り伸ばすと徐々に発泡する後発泡性エアゾール組成物が知られている。 Conventionally, various foamable aerosol compositions comprising an aqueous stock solution and a liquefied gas have been developed as aerosol compositions for shaving foams and the like. As these foamable aerosol compositions, after-foamable aerosol compositions that are discharged in a gel state and gradually foam when the gel is spread with a finger are known.
後発泡性エアゾール組成物としては、例えば、ゲル化剤、界面活性剤、水、後発泡剤、有効成分およびアルコール類からなり、常温大気圧下で少なくとも30秒間ゲル状を保ち、かつ、せん断応力を加えると発泡し、さらにせん断応力をかけ続けると短時間で消泡する、後発泡性ゲル組成物が知られている(例えば、特許文献1参照)。後発泡剤としては、イソペンタンおよびノルマルペンタンから選ばれる成分80重量%以上と、イソブタン、ノルマルブタン、プロパンおよびジメチルエーテルから選ばれる成分20重量%以下からなるものが開示されている。 The post-foaming aerosol composition is composed of, for example, a gelling agent, a surfactant, water, a post-foaming agent, an active ingredient, and alcohols, and maintains a gel state at room temperature and atmospheric pressure for at least 30 seconds, and shear stress. There is known a post-foaming gel composition that foams when added, and defoams in a short time when a shear stress is continuously applied (see, for example, Patent Document 1). As the post-foaming agent, a composition comprising 80% by weight or more of a component selected from isopentane and normal pentane and 20% by weight or less of a component selected from isobutane, normal butane, propane and dimethyl ether is disclosed.
また、水、石鹸、後発泡剤および特定の高級アルコールを含有する後発泡性エアゾール組成物が知られている(例えば、特許文献2参照)。該後発泡性エアゾール組成物は、エアゾール容器からゲル状物質の状態で吐出され、その後徐々に発泡してフォームを形成するものである。後発泡剤としては、沸点が−0.5〜36.5℃である低沸点有機液体が開示されており、具体的には、ノルマルペンタン、イソペンタン、ノルマルブタンが開示されている。 Further, a post-foaming aerosol composition containing water, soap, a post-foaming agent and a specific higher alcohol is known (see, for example, Patent Document 2). The post-foaming aerosol composition is discharged from an aerosol container in the form of a gel substance, and then gradually foams to form a foam. As the post-foaming agent, a low boiling point organic liquid having a boiling point of −0.5 to 36.5 ° C. is disclosed, and specifically, normal pentane, isopentane, and normal butane are disclosed.
しかし、特許文献1、2の後発泡性エアゾール組成物に用いられる後発泡剤としては、炭素数が3〜5個の脂肪族炭化水素やジメチルエーテルが開示されているが、実施例においては、イソペンタン、n−ペンタン、または、イソペンタンを主成分とするイソペンタンとn−ブタンの混合物が用いられているのみである。該炭素数が5個の脂肪族炭化水素の沸点は約28〜36℃であるため、実施例で用いられているような後発泡剤は、吐出直後は液体状態でゲルに分散しており、吐出したゲルに指でせん断を加えたり、皮膚からの熱により気化して発泡するものである。そのため一般的なゲルに比べて皮膚上で塗り伸ばしやすい、というメリットがあるものの、前述の脂肪族炭化水素はほとんどが皮膚上で気化するため刺激が強いという問題があった。さらに、ゲル状で吐出するため、エアゾール組成物を吐出する吐出部材の通路内にゲルが残りやすく、残ったゲルが後で発泡するアフタードローが発生し、吐出部材を汚すなどの問題があった。 However, as the post-foaming agent used in the post-foaming aerosol composition of Patent Documents 1 and 2, aliphatic hydrocarbons and dimethyl ether having 3 to 5 carbon atoms are disclosed. In the examples, isopentane is used. , N-pentane, or a mixture of isopentane and n-butane based on isopentane is used. Since the boiling point of the aliphatic hydrocarbon having 5 carbon atoms is about 28 to 36 ° C., the post-foaming agent used in the examples is dispersed in the gel in a liquid state immediately after discharge, The ejected gel is sheared with a finger or vaporized by heat from the skin to foam. Therefore, although there is a merit that it is easy to spread on the skin as compared with a general gel, there is a problem that most of the above-mentioned aliphatic hydrocarbons are vaporized on the skin and thus are highly irritating. Furthermore, since the gel is discharged, the gel tends to remain in the passage of the discharge member that discharges the aerosol composition, and there is a problem in that the remaining gel is foamed later and the discharge member is contaminated. .
また、陰イオン性界面活性剤を含有した水性原液と液化ガスとが特定の割合で乳化したエアゾール組成物が知られている(例えば、特許文献3参照)。該エアゾール組成物は、脂肪酸のケン化物等の陰イオン性界面活性剤を含有する水性原液を用いるものであり、泡状で吐出され、経時的に泡の形状が変化する(増大する)ものである。また、液化ガスとしては、プロパン、ノルマルブタン、イソブタンおよびこれらの混合物である液化石油ガス、ジメチルエーテル、フロン類が開示されており、その20℃での蒸気圧が0.1〜0.5MPaであることが好ましいことが開示されている。 In addition, an aerosol composition is known in which an aqueous stock solution containing an anionic surfactant and a liquefied gas are emulsified at a specific ratio (see, for example, Patent Document 3). The aerosol composition uses an aqueous stock solution containing an anionic surfactant such as a saponified fatty acid, and is discharged in the form of foam, and the foam shape changes (increases) over time. is there. Further, as liquefied gas, propane, normal butane, isobutane and mixtures thereof, liquefied petroleum gas, dimethyl ether and chlorofluorocarbons are disclosed, and the vapor pressure at 20 ° C. is 0.1 to 0.5 MPa. It is disclosed that it is preferable.
しかし、特許文献3のエアゾール組成物は、水性原液と液化ガスとの重量比が10/90〜60/40であり、液化ガスの割合が高いため、泡の比重が0.001〜0.005g/mlと非常に軽いものとなり、皮膚や頭髪上では塗り伸ばしにくいという問題があった。 However, in the aerosol composition of Patent Document 3, the weight ratio of the aqueous stock solution to the liquefied gas is 10/90 to 60/40, and the ratio of the liquefied gas is high, so the specific gravity of the foam is 0.001 to 0.005 g. / Ml was very light, and there was a problem that it was difficult to spread on the skin and hair.
したがって、泡状で吐出することができ、泡を指などで塗り伸ばすと徐々に起泡し、さらに泡状で吐出するため吐出部材の通路内に残る量が少なく、アフタードローを抑制でき、かつ皮膚への刺激がほとんどない発泡性エアゾール組成物はいまだ無いのが現状である。 Therefore, it can be discharged in the form of foam, and when the foam is spread with a finger or the like, the foam gradually rises, and since it is discharged in the form of foam, the amount remaining in the passage of the discharge member is small, and afterdraw can be suppressed, and At present, there is still no effervescent aerosol composition with almost no skin irritation.
本発明は、泡状で吐出することができ、泡を指などで塗り伸ばすと徐々に起泡し、さらに泡状で吐出するため吐出部材の通路内に残る量が少なく、アフタードローを抑制でき、かつ皮膚への刺激がほとんどない発泡性エアゾール組成物を提供することを目的とする。 The present invention can be discharged in the form of foam, and when foam is applied with a finger or the like, the foam gradually rises, and since it is discharged in the form of foam, the amount remaining in the passage of the discharge member is small, and afterdraw can be suppressed. An object of the present invention is to provide a foamable aerosol composition that hardly causes irritation to the skin.
すなわち、本発明は、界面活性剤を含有する水性原液70〜98重量%、沸点が50〜80℃であるハイドロフルオロエーテル0.5〜20重量%、および沸点が−50〜5℃である脂肪族炭化水素0.5〜10重量%を含有する発泡性エアゾール組成物に関する。 That is, the present invention relates to an aqueous stock solution containing a surfactant of 70 to 98% by weight, a hydrofluoroether having a boiling point of 50 to 80 ° C., 0.5 to 20% by weight, and a fat having a boiling point of −50 to 5 ° C. The present invention relates to a foamable aerosol composition containing 0.5 to 10% by weight of a group hydrocarbon.
界面活性剤の配合量が、水性原液中0.1〜20重量%であることが好ましい。 It is preferable that the compounding amount of the surfactant is 0.1 to 20% by weight in the aqueous stock solution.
脂肪族炭化水素の20℃での蒸気圧が、0.4〜0.7MPaであることが好ましい。 It is preferable that the vapor pressure of the aliphatic hydrocarbon at 20 ° C. is 0.4 to 0.7 MPa.
ハイドロフルオロエーテルと脂肪族炭化水素との配合比が、30/70〜90/10(重量比)であることが好ましい。 The blending ratio of hydrofluoroether and aliphatic hydrocarbon is preferably 30/70 to 90/10 (weight ratio).
本発明の発泡性エアゾール組成物は、界面活性剤を含有する水性原液、沸点が50〜80℃であるハイドロフルオロエーテル、および沸点が−50〜5℃である脂肪族炭化水素を特定の割合で含有することにより、泡状で吐出することができ、泡を指などで塗り伸ばすと徐々に起泡するため塗り伸ばしやすく、さらに泡状で吐出するため吐出部材の通路内に残る量が少なく、アフタードローを抑制できるものである。また、皮膚への刺激がほとんどないものである。 The foamable aerosol composition of the present invention comprises an aqueous stock solution containing a surfactant, a hydrofluoroether having a boiling point of 50 to 80 ° C., and an aliphatic hydrocarbon having a boiling point of −50 to 5 ° C. in a specific ratio. By containing, it can be discharged in the form of foam, and when foam is spread with fingers etc., it will gradually foam, so it is easy to spread, and since it is discharged in the form of foam, the amount remaining in the passage of the discharge member is small, It is possible to suppress afterdraw. Also, there is almost no irritation to the skin.
本発明の発泡性エアゾール組成物は、界面活性剤を含有する水性原液70〜98重量%、沸点が50〜80℃であるハイドロフルオロエーテル0.5〜20重量%、沸点が−50〜5℃である脂肪族炭化水素0.5〜10重量%を含有することにより、泡状で吐出することができ、泡を指などで塗り伸ばすと徐々に起泡するため塗り伸ばしやすく、さらに泡状で吐出するため吐出部材の通路内に残る量が少なく、アフタードローを抑制でき、かつ皮膚への刺激がほとんどないものである。 The foamable aerosol composition of the present invention has an aqueous stock solution containing a surfactant of 70 to 98% by weight, a hydrofluoroether having a boiling point of 50 to 80 ° C, 0.5 to 20% by weight, and a boiling point of -50 to 5 ° C. By containing 0.5 to 10% by weight of the aliphatic hydrocarbon, it can be discharged in the form of a foam. Since it is discharged, the amount remaining in the passage of the discharge member is small, afterdraw can be suppressed, and there is almost no irritation to the skin.
(A)水性原液
前記水性原液は、エアゾール容器内部では後述するハイドロフルオロエーテルと脂肪族炭化水素と乳化しており、大気中に吐出されると脂肪族炭化水素やハイドロフルオロエーテルの気化により起泡して泡(フォーム)を形成し、泡の液膜部分となる。
(A) Aqueous stock solution The aqueous stock solution is emulsified with a hydrofluoroether and an aliphatic hydrocarbon, which will be described later, inside the aerosol container, and when discharged into the atmosphere, foams due to the vaporization of the aliphatic hydrocarbon or the hydrofluoroether. Thus, bubbles are formed and become a liquid film portion of the bubbles.
水性原液の配合量は、エアゾール組成物中70〜98重量%であり、75〜95重量%であることが好ましい。水性原液が70重量%未満であると泡密度が小さくなりすぎ、使いにくくなる傾向があり、98重量%よりも多いと起泡が不充分で液密度が大きくなりすぎ、特に低温時はほとんど起泡せずに液状になる傾向がある。 The compounding quantity of an aqueous | water-based stock solution is 70 to 98 weight% in an aerosol composition, and it is preferable that it is 75 to 95 weight%. If the aqueous stock solution is less than 70% by weight, the foam density tends to be too small and difficult to use. If it is more than 98% by weight, foaming is insufficient and the liquid density becomes too large, particularly at low temperatures. There is a tendency to become liquid without foaming.
前記水性原液には、ハイドロフルオロエーテルと脂肪族炭化水素と乳化させるために、界面活性剤を含有している。 The aqueous stock solution contains a surfactant in order to emulsify the hydrofluoroether and the aliphatic hydrocarbon.
前記界面活性剤としては、例えば、ショ糖ステアリン酸エステル、ショ糖ミリスチン酸エステル、ショ糖ラウリン酸エステルなどのショ糖脂肪酸エステル、ラウリルグルコシド、デシルグルコシドなどのアルキルポリグルコシド、ソルビタン脂肪酸エステル、モノグリセリン脂肪酸エステル、ジ、トリ、テトラ、ペンタ、ヘキサ、デカなどのポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンヒマシ油・硬化ヒマシ油、ポリオキシエチレンラノリンアルコール、ポリオキシエチレンアルキルアミン、ポリオキシエチレン脂肪酸アミド、ヤシ油脂肪酸ジエタノールアミドなどの脂肪酸アルキロールアミド、ポリオキシエチレン・メチルポリシロキサン共重合体、ポリオキシプロピレン・メチルポリシロキサン共重合体、ポリ(オキシエチレン・オキシプロピレン)・メチルポリシロキサン共重合体などの非イオン性界面活性剤や、カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸などの炭素数が10〜20個の脂肪酸を、2−アミノ−2−メチル−1−プロパノール、トリエタノールアミン、ジエタノールアミン、ジイソプロパノールアミン、水酸化ナトリウム、水酸化カリウムなどのアルカリ剤でケン化した脂肪酸石鹸、N−ヤシ油脂肪酸アシル−L−グルタミン酸トリエタノールアミン、N−ヤシ油脂肪酸アシル−L−グルタミン酸カリウム、N−ヤシ油脂肪酸アシル−L−グルタミン酸ナトリウム、N−ラウロイル−L−グルタミン酸トリエタノールアミン、N−ラウロイル−L−グルタミン酸カリウム、N−ラウロイル−L−グルタミン酸ナトリウム、N−ミリストイル−L−グルタミン酸カリウム、N−ミリストイル−L−グルタミン酸ナトリウム、N−ステアロイル−L−グルタミン酸ナトリウムなどのN−アシルグルタミン酸塩;N−ヤシ油脂肪酸アシルグリシンカリウム、N−ヤシ油脂肪酸アシルグリシンナトリウムなどのN−アシルグリシン塩;N−ヤシ油脂肪酸アシル−DL−アラニントリエタノールアミンなどのN−アシルアラニン塩;などのアミノ酸石鹸、アクリル酸・メタアクリル酸アルキル共重合体などの高分子乳化剤(前記アルカリ剤で中和したものを含む)、などがあげられ、これらを単独でまたは2種以上混合して用いることができる。これらの中でも、ハイドロフルオロエーテルとの乳化安定性に優れている点から、ショ糖脂肪酸エステル、アルキルポリグルコシド、脂肪酸アルキロールアミド、脂肪酸石鹸、アクリル酸・メタアクリル酸アルキル共重合体が好ましい。 Examples of the surfactant include sucrose fatty acid esters such as sucrose stearic acid ester, sucrose myristic acid ester, and sucrose lauric acid ester, alkylpolyglucosides such as lauryl glucoside and decyl glucoside, sorbitan fatty acid ester, and monoglycerin. Fatty acid ester, polyglycerin fatty acid ester such as di, tri, tetra, penta, hexa, deca, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene poly Oxypropylene alkyl ether, polyoxyethylene castor oil / hardened castor oil, polyoxyethylene lanolin alcohol, polyoxyethylene alkylamine Fatty acid alkylolamides such as polyoxyethylene fatty acid amide and coconut oil fatty acid diethanolamide, polyoxyethylene / methylpolysiloxane copolymer, polyoxypropylene / methylpolysiloxane copolymer, poly (oxyethylene / oxypropylene) / methyl Nonionic surfactants such as polysiloxane copolymers and fatty acids having 10 to 20 carbon atoms such as capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, -Fatty acid soap saponified with an alkaline agent such as methyl-1-propanol, triethanolamine, diethanolamine, diisopropanolamine, sodium hydroxide, potassium hydroxide, N-coconut oil fatty acid acyl-L-glutamic acid triethanolamine, N -Palm oil Acyl fatty acid-potassium L-glutamate, N-coconut oil fatty acid acyl-sodium L-glutamate, N-lauroyl-L-glutamate triethanolamine, N-lauroyl-L-potassium glutamate, N-lauroyl-L-glutamate sodium, N-acyl glutamates such as N-myristoyl-L-glutamate potassium, N-myristoyl-L-sodium glutamate, N-stearoyl-L-glutamate sodium; N-coconut oil fatty acid acylglycine potassium, N-coconut oil fatty acid acylglycine N-acylglycine salts such as sodium; N-acylalanine salts such as N-coconut oil fatty acid acyl-DL-alanine triethanolamine; amino acid soaps such as high molecular milk such as acrylic acid / alkyl methacrylate copolymers And the like (including those neutralized with the alkali agent), and the like. These can be used alone or in admixture of two or more. Among these, sucrose fatty acid ester, alkyl polyglucoside, fatty acid alkylolamide, fatty acid soap, and acrylic acid / methacrylic acid alkyl copolymer are preferable from the viewpoint of excellent emulsification stability with hydrofluoroether.
前記界面活性剤の配合量は、水性原液中0.1〜20重量%であることが好ましく、0.1〜15重量%であることがより好ましく、0.5〜10重量%であることがさらに好ましく、1〜10重量%であることが特に好ましい。前記界面活性剤の配合量が0.1重量%未満であると乳化力および起泡力が弱くなり、吐出時に安定した泡を形成しにくくなる傾向があり、20重量%より多いとべたつき感が強くなる、乾燥性が悪くなるなど、使用感が低下する傾向がある。 The amount of the surfactant is preferably 0.1 to 20% by weight in the aqueous stock solution, more preferably 0.1 to 15% by weight, and 0.5 to 10% by weight. More preferred is 1 to 10% by weight. If the blending amount of the surfactant is less than 0.1% by weight, the emulsifying power and foaming power tend to be weak, and it is difficult to form a stable foam at the time of ejection. There is a tendency for the feeling of use to decrease, for example, it becomes stronger and the drying property becomes worse.
前記水性原液は、前記界面活性剤とともに、用途や目的などに応じて有効成分、アルコール類、水溶性高分子、油性成分、粉末などを適宜選択し、水に配合することにより調製することができる。 The aqueous stock solution can be prepared by appropriately selecting an active ingredient, alcohols, water-soluble polymer, oily component, powder and the like together with the surfactant according to the use and purpose, and blending in water. .
前記有効成分は、用途や目的などに応じた効果を付与するために用いられる。前記有効成分としては、例えば、アルギニン、グリシン、アラニン、セリン、グルタミンなどのアミノ酸;レチノール、酢酸レチノール、パルミチン酸レチノール、パントテン酸カルシウム、アスコルビン酸、アスコルビン酸ナトリウム、dl−α−トコフェロール、酢酸トコフェロール、およびこれらの混合物などのビタミン;l−メントール、カンフルなどの清涼剤;酸化亜鉛、アラントインヒドロキシアルミニウム、タンニン酸、クエン酸、乳酸などの収斂剤;アルブチン、コウジ酸などの美白剤;ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、パラメトキシケイ皮酸2−エチルヘキシル、エチルヘキシルトリアゾン、オキシベンゾン、ヒドロキシベンゾフェノンスルホン酸、ジヒドロキシベンゾフェノンスルホン酸ナトリウム、ジヒドロキシベンゾフェノンなどの紫外線吸収剤;酸化亜鉛、酸化チタン、オクチルトリメトキシシラン被覆酸化チタンなどの紫外線散乱剤;ポリビニルピロリドン、酢酸ビニル・ビニルピロリドン共重合体、ポリビニルカプロラクタム、N−ビニルピロリドン・メタクリルアミド・N−ビニルイミダゾール共重合体などのノニオン性ポリマー、ビニルピロリドン・N,N−ジメチルアミノエチルメタクリル酸共重合体ジエチル硫酸塩(ポリクオタニウム11)、塩化メチルビニルイミダゾリウム・ビニルピロリドン共重合体、メチルビニルイミダゾリウム・ビニルピロリドン共重合体メチル硫酸塩などの他のカチオン性ポリマーなどのスタイリング成分;サリチル酸メチル、カンフル、ジフェンヒドラミン、インドメタシン、ピロキシカム、フェルビナク、ケトプロフェン、クロタミトンなどの消炎鎮痛剤;アラントイン、グリチルレチン酸、アズレンなどの抗炎症剤;塩酸ジブカイン、塩酸テトラカイン、塩酸リドカインなどの局所麻酔剤;塩酸ジフェンヒドラミン、マレイン酸クロルフェミラミンなどの抗ヒスタミン剤;フローラル、グリーン、シトラスグリーン、グリーンフローラル、シトラス、ローズ、ローズウッド、ハーバルウッド、レモン、ペパーミントなどの香料;パラオキシ安息香酸エステル、フェノキシエタノールなどの防腐剤などがあげられ、これらを用途や目的などに応じて単独でまたは2種以上を混合して用いることができる。 The said active ingredient is used in order to provide the effect according to a use, a purpose, etc. Examples of the active ingredient include amino acids such as arginine, glycine, alanine, serine, and glutamine; retinol, retinol acetate, retinol palmitate, calcium pantothenate, ascorbic acid, sodium ascorbate, dl-α-tocopherol, tocopherol acetate, And vitamins such as mixtures thereof; refreshing agents such as l-menthol and camphor; astringents such as zinc oxide, allantoin hydroxyaluminum, tannic acid, citric acid and lactic acid; whitening agents such as arbutin and kojic acid; diethylaminohydroxybenzoyl benzoate Acid hexyl, paramethoxycinnamate 2-ethylhexyl, ethylhexyltriazone, oxybenzone, hydroxybenzophenonesulfonic acid, dihydroxybenzophenonesulfonic acid sodium UV absorbers such as zinc and dihydroxybenzophenone; UV scattering agents such as zinc oxide, titanium oxide and octyltrimethoxysilane-coated titanium oxide; polyvinylpyrrolidone, vinyl acetate / vinylpyrrolidone copolymer, polyvinylcaprolactam, N-vinylpyrrolidone / methacrylic Nonionic polymers such as amide / N-vinylimidazole copolymer, vinyl pyrrolidone / N, N-dimethylaminoethyl methacrylate copolymer diethyl sulfate (polyquaternium 11), methyl vinyl imidazolium chloride / vinyl pyrrolidone copolymer, Styling components such as methyl vinyl imidazolium / vinyl pyrrolidone copolymer and other cationic polymers such as methyl sulfate; methyl salicylate, camphor, diphenhydramine, indomethacin, pyroxy Anti-inflammatory analgesics such as cam, felbinac, ketoprofen, crotamiton; anti-inflammatory agents such as allantoin, glycyrrhetinic acid, azulene; local anesthetics such as dibucaine hydrochloride, tetracaine hydrochloride, lidocaine hydrochloride; diphenhydramine hydrochloride, chlorfemiramin maleate, etc. Antihistamines; fragrances such as floral, green, citrus green, green floral, citrus, rose, rosewood, herbal wood, lemon, peppermint; antiseptics such as paraoxybenzoate, phenoxyethanol, etc. Depending on the case, they can be used alone or in admixture of two or more.
前記有効成分の配合量は、水性原液中0.1〜20重量%であることが好ましく、0.5〜10重量%であることがより好ましい。前記有効成分の配合量が0.1重量%未満であると有効成分濃度が低くなるため所望の効果を得るためには使用量が多くなる傾向があり、20重量%より多いと、有効成分濃度が高くなりすぎ、使用上限を超えて塗布しやすくなる。 The compounding amount of the active ingredient is preferably 0.1 to 20% by weight, more preferably 0.5 to 10% by weight in the aqueous stock solution. If the blending amount of the active ingredient is less than 0.1% by weight, the active ingredient concentration decreases, so that the amount used tends to increase in order to obtain the desired effect. Becomes too high, making it easier to apply over the upper limit of use.
前記アルコール類は、起泡状態や泡の持続性、消泡性などの発泡性を調整するためや、水に溶解しにくい有効成分などを配合するためなどの目的で用いられる。 The alcohols are used for the purpose of adjusting the foaming state, foam sustainability, foaming properties such as defoaming properties, and blending active ingredients that are difficult to dissolve in water.
前記アルコール類としては、例えば、エタノール、イソプロパノールなどの炭素数が2〜3個の1価アルコール、エチレングリコール、ジエチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなどの2〜3価のアルコールがあげられ、これらを単独でまたは2種以上を混合して用いることができる。これらの中でも、吐出時の起泡性および泡の持続性に優れ、さらにハイドロフルオロエーテルにより起泡しやすい点から、2〜3価のアルコールが好ましい。 Examples of the alcohols include monohydric alcohols having 2 to 3 carbon atoms such as ethanol and isopropanol, and dihydric alcohols such as ethylene glycol, diethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin. These can be used alone or in admixture of two or more. Among these, a divalent alcohol is preferable because it is excellent in foaming property at the time of discharge and the sustainability of the foam, and more easily foamed with hydrofluoroether.
前記アルコール類を配合する場合の配合量は、水性原液中0.5〜30重量%であることが好ましく、1〜25重量%であることがより好ましい。アルコール類の配合量が0.5重量%未満であると、アルコール類を配合する効果が得られにくい傾向があり、30重量%よりも多いと、起泡しにくくなるなど、発泡性が低下しやすくなる傾向がある。 The blending amount when blending the alcohols is preferably 0.5 to 30% by weight, more preferably 1 to 25% by weight in the aqueous stock solution. If the blending amount of the alcohol is less than 0.5% by weight, the effect of blending the alcohol tends to be difficult to obtain. If the blending amount is more than 30% by weight, the foaming property is reduced, such as difficulty in foaming. It tends to be easier.
前記水溶性高分子は、水性原液の粘度を調整して、脂肪族炭化水素やハイドロフルオロエーテルとの乳化を安定化する、泡の硬さや弾力性、持続性、消泡性を調整するなどの目的で用いられる。 The water-soluble polymer stabilizes the emulsification with an aliphatic hydrocarbon or hydrofluoroether by adjusting the viscosity of the aqueous stock solution, and adjusts the hardness and elasticity of the foam, the durability, the defoaming property, etc. Used for purposes.
前記水溶性高分子としては、例えば、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロース、ニトルセルロース、結晶セルロース、メチルセルロース、エチルセルロースなどのセルロース類;キサンタンガム、ジェランガム、カラギーナン、グアガムなどのガム類;寒天、デキストリン、ペクチン、デンプン、ゼラチン、ゼラチン加水分解物、アルギン酸ナトリウム、変性ポテトスターチ、ポリビニルアルコール、カルボキシビニルポリマーなどがあげられ、これらを単独でまたは2種以上を混合して用いることができる。 Examples of the water-soluble polymer include celluloses such as hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, nitrile cellulose, crystalline cellulose, methyl cellulose, and ethyl cellulose; gums such as xanthan gum, gellan gum, carrageenan, and guar gum; agar, dextrin, Pectin, starch, gelatin, gelatin hydrolyzate, sodium alginate, modified potato starch, polyvinyl alcohol, carboxyvinyl polymer and the like can be mentioned, and these can be used alone or in admixture of two or more.
前記水溶性高分子を配合する場合の配合量は、水性原液中0.01〜5重量%であることが好ましく、0.05〜3重量%であることがより好ましい。水溶性高分子の配合量が0.01重量%未満であると、水性原液の粘度を調整する効果が得られにくい傾向があり、5重量%よりも多いと、水性原液の粘度が高くなりすぎ、脂肪族炭化水素やハイドロフルオロエーテルとの乳化が困難になるなど、取り扱いにくくなる傾向がある。 In the case of blending the water-soluble polymer, the blending amount is preferably 0.01 to 5% by weight, more preferably 0.05 to 3% by weight in the aqueous stock solution. If the blending amount of the water-soluble polymer is less than 0.01% by weight, the effect of adjusting the viscosity of the aqueous stock solution tends to be difficult to obtain. If it exceeds 5% by weight, the viscosity of the aqueous stock solution becomes too high. , It tends to be difficult to handle, such as difficulty in emulsification with aliphatic hydrocarbons and hydrofluoroethers.
前記油性成分は、肌触りを良くする、すべりや櫛通りを良くする、保湿性を向上させる、ツヤを出すなど、使用感を向上させる目的で用いられる。 The oil component is used for the purpose of improving the feeling of use, such as improving the touch, improving sliding and combing, improving the moisture retention, and giving gloss.
前記油性成分としては、例えば、アジピン酸ジイソプロピル、コハク酸ジエトキシエチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピルなどのエステル油;メチルポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、メチルシクロポリシロキサン、テトラヒドロテトラメチルシクロテトラシロキサン、オクタメチルトリシロキサン、デカメチルテトラシロキサン、メチルフェニルポリシロキサンなどのシリコーンオイル;ジメチコンクロスポリマー、ジメチコン・ビニルジメチコンクロスポリマー、ジメチコン・フェニルジメチコンクロスポリマー、ジメチコン・コポリオールクロスポリマーなどのシリコーンエラストマー;スクワラン、スクワレン、流動パラフィン、イソパラフィンなどの液状の炭化水素;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、イソステアリン酸、リノール酸、リノレイン酸などの脂肪酸;ラウリルアルコール、ミリスチルアルコール、セチルアルコール、ステアリルアルコール、アラキルアルコール、ベヘニルアルコール、ラノリンアルコールなどの高級アルコール;アボガド油、マカダミアナッツ油、シア脂、オリーブ油、ツバキ油などの油脂;ミツロウ、ラノリンロウ、キャンデリラロウ、パラフィンワックスなどのロウ類などがあげられ、これらを単独でまたは2種以上を混合して用いることができる。なお、前記油性成分のうち常温で固体であるものを用いることで泡の硬さや弾力性、持続性を調整することができる。 Examples of the oil component include ester oils such as diisopropyl adipate, diethoxyethyl succinate, isopropyl myristate, isopropyl palmitate; methyl polysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexa Silicone oils such as siloxane, methylcyclopolysiloxane, tetrahydrotetramethylcyclotetrasiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, methylphenylpolysiloxane; dimethicone crosspolymer, dimethicone / vinyl dimethicone crosspolymer, dimethicone / phenyldimethicone crosspolymer , Silicone elastomers such as dimethicone / copolyol crosspolymer; squalane, squale Liquid hydrocarbons such as liquid paraffin and isoparaffin; fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, isostearic acid, linoleic acid, linolenic acid; lauryl alcohol, myristyl alcohol, cetyl alcohol , Higher alcohols such as stearyl alcohol, aralkyl alcohol, behenyl alcohol, lanolin alcohol; fats such as avocado oil, macadamia nut oil, shea fat, olive oil, camellia oil; waxes such as beeswax, lanolin wax, candelilla wax, paraffin wax, etc. These can be used alone or in admixture of two or more. In addition, the hardness of a foam, elasticity, and sustainability can be adjusted by using what is a solid at normal temperature among the said oil-based components.
前記油性成分を配合する場合の配合量は、水性原液中0.1〜10重量%であることが好ましく、0.5〜5重量%であることがより好ましい。油性成分の配合量が0.1重量%未満であると、油性成分の配合効果が得られにくい傾向があり、10重量%よりも多いと、水性原液が分離しやすく、さらに水性原液と脂肪族炭化水素、ハイドロフルオロエーテルとが分離しやすくなる傾向がある。 The blending amount when blending the oily component is preferably 0.1 to 10% by weight, more preferably 0.5 to 5% by weight in the aqueous stock solution. When the blending amount of the oil component is less than 0.1% by weight, the blending effect of the oil component tends to be difficult to obtain. When the blending amount is more than 10% by weight, the aqueous stock solution is easily separated. There is a tendency that hydrocarbons and hydrofluoroethers are easily separated.
前記水は水性原液の主溶媒であり、水としては、例えば、精製水、イオン交換水、生理食塩水、海洋深層水などがあげられる。なお、水に前記アルコール類を添加して水性溶媒として用いてもよい。 The water is a main solvent of the aqueous stock solution, and examples of the water include purified water, ion exchange water, physiological saline, and deep ocean water. The alcohols may be added to water and used as an aqueous solvent.
水の配合量は、水性原液中60〜98重量%であることが好ましく、70〜95重量%であることがより好ましい。水の配合量が60重量%未満であると、起泡性および泡の安定性が低下しやすい傾向があり、98重量%よりも多いと、界面活性剤や他の成分の配合量が少なくなって、所望の効果が得られにくい傾向がある。 The blending amount of water is preferably 60 to 98% by weight, more preferably 70 to 95% by weight in the aqueous stock solution. If the blending amount of water is less than 60% by weight, the foamability and foam stability tend to be lowered, and if it is more than 98% by weight, the blending amount of the surfactant and other components decreases. Therefore, the desired effect tends to be difficult to obtain.
前記水性原液は、界面活性剤や有効成分などを水に配合することにより調製することができる。なお、水に溶解しにくい、あるいは水に溶解しない有効成分や油性成分などは、アルコール類に可溶化してから添加してもよく、原液の状態で水と乳化させてもよい。 The aqueous stock solution can be prepared by blending a surfactant, an active ingredient and the like with water. It should be noted that an active ingredient or an oily ingredient that is difficult to dissolve in water or insoluble in water may be added after solubilization in alcohols, or may be emulsified with water in the state of a stock solution.
(B)ハイドロフルオロエーテル
前記沸点が50〜80℃であるハイドロフルオロエーテルは、泡を塗り伸ばしたときに大部分が気化して起泡を継続させる、刺激を低下させて、感じないようにするなどの目的で用いられ、例えば、メチルパーフルオロブチルエーテル(沸点61℃)、エチルパーフルオロブチルエーテル(沸点76℃)、およびこれらの混合物などがあげられる。これらの中でも、泡を塗り伸ばしたときに起泡を継続させやすい点からメチルパーフルオロブチルエーテルが好ましい。
(B) Hydrofluoroether The hydrofluoroether having a boiling point of 50 to 80 ° C. is mostly vaporized when foam is spread out to continue foaming. Examples thereof include methyl perfluorobutyl ether (boiling point 61 ° C.), ethyl perfluorobutyl ether (boiling point 76 ° C.), and mixtures thereof. Among these, methyl perfluorobutyl ether is preferable because it is easy to continue foaming when the foam is spread.
前記ハイドロフルオルエーテルの沸点は50〜80℃であり、60〜80℃であることが好ましい。沸点が50℃未満であると、体温や外気温により気化しやすくなり刺激が強くなる傾向があり、80℃よりも高いと、指などでマッサージしても気化しにくくなり起泡が継続しにくい傾向がある。 The boiling point of the hydrofluoroether is 50 to 80 ° C, preferably 60 to 80 ° C. If the boiling point is less than 50 ° C, it tends to evaporate due to body temperature or outside air temperature, and the irritation tends to be strong. If it is higher than 80 ° C, it is difficult to evaporate even if massaged with fingers, and foaming is difficult to continue. Tend.
前記ハイドロフルオロエーテルの配合量は、エアゾール組成物中0.5〜20重量%であり、1〜20重量%であることが好ましく、1〜15重量%であることがより好ましい。ハイドロフルオロエーテルの配合量が0.5重量%未満であると、起泡が持続しにくくなる傾向があり、20重量%よりも多いと、起泡の持続が長くなりすぎ、逆に泡が消えにくくなる傾向がある。 The blending amount of the hydrofluoroether is 0.5 to 20% by weight in the aerosol composition, preferably 1 to 20% by weight, and more preferably 1 to 15% by weight. If the blending amount of the hydrofluoroether is less than 0.5% by weight, foaming tends to be difficult to sustain, and if it exceeds 20% by weight, the foaming lasts too long, and the foam disappears. There is a tendency to become difficult.
(C)脂肪族炭化水素
前記沸点が−50〜5℃である脂肪族炭化水素は、吐出時に気化してエアゾール組成物を泡状で吐出するために用いられる。沸点が−50〜5℃である脂肪族炭化水素を含むことで、泡状で吐出することができるためアフタードローを抑制することができる。
(C) Aliphatic hydrocarbon The aliphatic hydrocarbon having a boiling point of −50 to 5 ° C. is vaporized during discharge and used to discharge the aerosol composition in the form of foam. By including an aliphatic hydrocarbon having a boiling point of −50 to 5 ° C., after-draw can be suppressed because it can be discharged in a foam state.
前記脂肪族炭化水素の沸点は、−50〜5℃であるが、−50〜0℃であることが好ましく、−45〜−5℃であることがより好ましい。脂肪族炭化水素の沸点が−50℃未満であると、蒸気圧が高くなりすぎ、吐出時に飛散しやすくなる傾向があり、5℃よりも高いと、皮膚の表面温度や周囲の温度により皮膚上で気化しやすく、皮膚への刺激が強くなる傾向がある。 The boiling point of the aliphatic hydrocarbon is −50 to 5 ° C., preferably −50 to 0 ° C., and more preferably −45 to −5 ° C. If the boiling point of the aliphatic hydrocarbon is less than −50 ° C., the vapor pressure tends to be too high, and it tends to be scattered during discharge. If it is higher than 5 ° C., the surface temperature of the skin and the surrounding temperature may cause It tends to evaporate and tends to irritate the skin.
沸点が−50〜5℃である脂肪族炭化水素としては、例えば、プロパン(沸点−42.0℃)、ノルマルブタン(沸点−0.5℃)、イソブタン(沸点−11.7℃)などの炭素数が3〜4個の脂肪族炭化水素、およびこれらの混合物などがあげられる。 Examples of the aliphatic hydrocarbon having a boiling point of −50 to 5 ° C. include propane (boiling point −42.0 ° C.), normal butane (boiling point −0.5 ° C.), and isobutane (boiling point −11.7 ° C.). Examples thereof include aliphatic hydrocarbons having 3 to 4 carbon atoms and mixtures thereof.
なお、脂肪族炭化水素は前記成分を混合して所望の蒸気圧に調整され、特に吐出時の起泡性および発泡の継続性に優れる点から、20℃での蒸気圧が0.4〜0.7MPaであるものを用いることが好ましく、0.45〜0.6MPaであるものを用いることがより好ましい。なお、脂肪族炭化水素が前記蒸気圧の範囲内になるよう調整するために、プロパンを脂肪族炭化水素中40〜90重量%、さらには45〜80重量%含有するものが好ましい。 In addition, the aliphatic hydrocarbon is adjusted to a desired vapor pressure by mixing the above-mentioned components, and in particular, the vapor pressure at 20 ° C. is 0.4 to 0 from the viewpoint of excellent foaming property and continuity of foaming. It is preferable to use a material having a pressure of 0.7 MPa, and it is more preferable to use a material having a pressure of 0.45 to 0.6 MPa. In order to adjust the aliphatic hydrocarbon to be within the range of the vapor pressure, it is preferable that propane is contained in the aliphatic hydrocarbon in an amount of 40 to 90% by weight, more preferably 45 to 80% by weight.
前記脂肪族炭化水素の配合量は、エアゾール組成物中0.5〜10重量%であり、1〜8重量%であることが好ましい。脂肪族炭化水素の配合量が0.5重量%未満であると、吐出時の起泡性が小さく泡密度が大きくなるため泡状で吐出しにくく、またアフタードローが多くなりやすい傾向がある。10重量%よりも多いと、起泡性が大きく泡密度が小さくなるため粗い泡になり、さらに起泡が継続しにくくなる傾向がある。 The blending amount of the aliphatic hydrocarbon is 0.5 to 10% by weight, preferably 1 to 8% by weight, in the aerosol composition. When the blending amount of the aliphatic hydrocarbon is less than 0.5% by weight, the foaming property at the time of discharge is small and the bubble density is large, so that the foam is difficult to be discharged and the after-draw tends to increase. When the amount is more than 10% by weight, the foamability is large and the foam density is small, so that the foam becomes rough and the foaming tends to be difficult to continue.
なお、前記ハイドロフルオルエーテルと脂肪族炭化水素との配合比は、30/70〜90/10(重量比)であることが好ましく、40/60〜80/20であることがより好ましい。配合比が30/70未満であると、起泡が継続しにくくなる傾向があり、90/10よりも大きいと、吐出時の起泡が弱く、泡状で吐出しにくくなる傾向がある。 The blending ratio of the hydrofluoroether and the aliphatic hydrocarbon is preferably 30/70 to 90/10 (weight ratio), and more preferably 40/60 to 80/20. When the blending ratio is less than 30/70, foaming tends to be difficult to continue, and when it is larger than 90/10, foaming at the time of discharge tends to be weak and tends to be foamy and difficult to discharge.
このように構成される本発明の発泡性エアゾール組成物は、前記界面活性剤、必要に応じて配合される有効成分、水溶性高分子などを水性溶媒に配合して水性原液を調製し、得られた水性原液をハイドロフルオロエーテル、脂肪族炭化水素とともにエアゾール用容器に充填し、水性原液にハイドロフルオロエーテルと脂肪族炭化水素とを乳化することにより調製することができる。なお、水性原液とハイドロフルオロエーテルを予め乳化したものをエアゾール容器内に充填し、これに脂肪族炭化水素を添加して乳化させても良い。 The foamable aerosol composition of the present invention constructed as described above is obtained by preparing an aqueous stock solution by blending the surfactant, an active ingredient blended as necessary, a water-soluble polymer, etc. in an aqueous solvent. The resulting aqueous stock solution can be prepared by filling an aerosol container together with hydrofluoroether and aliphatic hydrocarbon, and emulsifying the hydrofluoroether and aliphatic hydrocarbon in the aqueous stock solution. In addition, what pre-emulsified aqueous undiluted | stock solution and hydrofluoroether may be filled in an aerosol container, and an aliphatic hydrocarbon may be added to this and emulsified.
得られた発泡性エアゾール組成物は、エアゾール容器から大気中に放出されると、脂肪族炭化水素が気化して水性原液を発泡させて泡状になる。得られた泡を皮膚や頭髪に塗布し、さらに指先やブラシなどを用いて塗り伸ばす、あるいはカミソリで剃るとハイドロフルオロエーテルがゆっくりと気化して起泡するため塗布面上で塗り伸ばしやすいものである。 When the resulting foamable aerosol composition is released from the aerosol container into the atmosphere, the aliphatic hydrocarbons are vaporized to foam the aqueous stock solution into a foam. Apply the obtained foam to the skin and hair, and then apply with a fingertip or brush, or if you shave with a razor, hydrofluoroether will slowly evaporate and foam, making it easy to apply on the coated surface. is there.
本発明の発泡性エアゾール組成物は、シェービングフォーム、洗顔フォーム、クレンジングフォーム、スキンケア用フォーム、鎮痒剤用フォーム、消炎鎮痛剤用フォームなどの皮膚用製品や、スタイリングフォーム、トリートメントフォーム、ワックスフォームなどの頭髪用製品などに用いることができる。 The foamable aerosol composition of the present invention can be used for skin products such as shaving foam, facial cleansing foam, cleansing foam, skin care foam, antipruritic foam, anti-inflammatory analgesic foam, styling foam, treatment foam, wax foam, etc. It can be used for hair products.
以下、実施例によって本発明を具体的に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not limited thereto.
評価方法を下記に示す。 The evaluation method is shown below.
<吐出状態>
エアゾール容器にスパウトを装着し、エアゾール製品を25℃の恒温水槽中に1時間保持してエアゾール組成物を吐出し、以下の基準により評価した。
○:発泡した状態で吐出され、泡を指で塗り拡げると再度発泡した。
△1:吐出時の発泡は小さいが、泡を指で塗り拡げると再度発泡した。
△2:発泡した状態で吐出されるが、泡を指で塗り拡げたときの再発泡が小さい。
×1:ほとんど発泡せずに液体状態で吐出され、指で塗り拡げると発泡した。
×2:発泡した状態で吐出されるが、泡を指で塗り拡げても再発泡しない。
<Discharge state>
A spout was attached to the aerosol container, the aerosol product was kept in a constant temperature water bath at 25 ° C. for 1 hour, and the aerosol composition was discharged. Evaluation was performed according to the following criteria.
○: Discharged in a foamed state, and foamed again when the foam was spread with fingers.
Δ1: Foaming at the time of discharge was small, but when the foam was spread with fingers, it foamed again.
Δ2: Discharged in a foamed state, but re-foaming when foam is spread with fingers is small.
X1: It was discharged in a liquid state with almost no foaming, and foamed when spread with fingers.
X2: Although it is discharged in a foamed state, it does not re-foam even if the foam is spread with a finger.
<泡の伸展性>
吐出した泡を手のひらで拡げてから頬に塗布し、指先で塗り拡げたときの状態を、以下の基準により評価した。
○:泡が滑らかに伸び、途切れることなく薄く伸ばすことができる。
△:泡は伸びるが、途切れる部分がある。
×:泡が伸びにくく、途切れる。
<Bubble extensibility>
The state when the discharged foam was spread on the cheek after spreading with the palm and spread with the fingertips was evaluated according to the following criteria.
○: Bubbles can be smoothly stretched and stretched thinly without interruption.
(Triangle | delta): Although a bubble expands, there exists a part interrupted.
X: Bubbles are difficult to stretch and break.
<皮膚への刺激>
泡を頬に塗布したときの刺激の有無を、以下の基準により評価した。
○:刺激は感じられない。
×:刺激が感じられる。
<Skin irritation>
The presence or absence of irritation when foam was applied to the cheek was evaluated according to the following criteria.
○: No irritation is felt.
X: Stimulation is felt.
<アフタードロー>
泡を吐出した後、スパウトの吐出孔から吐出される残留物(アフタードロー)の有無を、以下の基準により評価した。
○:アフタードローはほとんどない。
△:少量のアフタードローがある。
×:長時間に渡ってアフタードローが続く。
<After Draw>
After the foam was discharged, the presence or absence of a residue (after-draw) discharged from the spout discharge hole was evaluated according to the following criteria.
○: Almost no after-draw.
Δ: There is a small amount of after-draw.
X: After draw continues for a long time.
実施例1
下記の水性原液を調製し、水性原液69.6gとエチルパーフルオロブチルエーテル8.0gを乳化させた。次いで、この乳化物77.6gをアルミニウム製耐圧容器に充填し、容器の開口部にエアゾールバルブを固着した。さらにバルブから液化石油ガスを2.4g充填し、容器を上下に振って乳化させ、エアゾール組成物を製造した。得られたエアゾール組成物の評価結果を表1に示す。
Example 1
The following aqueous stock solution was prepared, and 69.6 g of the aqueous stock solution and 8.0 g of ethyl perfluorobutyl ether were emulsified. Next, 77.6 g of this emulsion was filled in an aluminum pressure vessel, and an aerosol valve was fixed to the opening of the vessel. Furthermore, 2.4g of liquefied petroleum gas was filled from the valve | bulb, and the container was shaken up and down to emulsify and the aerosol composition was manufactured. The evaluation results of the obtained aerosol composition are shown in Table 1.
<水性原液>
ラウリン酸スクロース(*1) 5.0
1,3−ブチレングリコール 5.0
グリセリン 5.0
アクリレーツ・アクリル酸アルキル
(C10−30)クロスポリマー(*2) 0.4
2−アミノ−2−エチル−1−プロパノール 0.3
メチルパラベン 0.2
フェノキシエタノール 0.2
精製水 83.9
合計 100.0(重量%)
<Aqueous stock solution>
Sucrose laurate (* 1) 5.0
1,3-butylene glycol 5.0
Glycerin 5.0
Acrylates / alkyl acrylate (C10-30) Crosspolymer (* 2) 0.4
2-Amino-2-ethyl-1-propanol 0.3
Methylparaben 0.2
Phenoxyethanol 0.2
Purified water 83.9
Total 100.0 (% by weight)
<エアゾール組成物>
上記水性原液 87.0
エチルパーフルオロブチルエーテル(*3) 10.0
液化石油ガス(*4) 3.0
合計 100.0(重量%)
*1:コスメライクL−160A(商品名)、第一工業製薬(株)製
*2:ベミュレンTR−1(商品名)、NOVEON製
*3:CF−76(商品名)、住友スリーエム(株)製
*4:20℃での蒸気圧が0.54MPa
プロパン:イソブタン:ノルマルブタン=60:10:30(重量比)
<Aerosol composition>
The above aqueous stock solution 87.0
Ethyl perfluorobutyl ether (* 3) 10.0
Liquefied petroleum gas (* 4) 3.0
Total 100.0 (% by weight)
* 1: Cosmelike L-160A (trade name), manufactured by Daiichi Kogyo Seiyaku Co., Ltd. * 2: Bemulen TR-1 (trade name), manufactured by NOVEON * 3: CF-76 (trade name), Sumitomo 3M Co., Ltd. * 4: Vapor pressure at 20 ° C is 0.54 MPa
Propane: isobutane: normal butane = 60: 10: 30 (weight ratio)
実施例2(洗顔フォーム)
下記の水性原液を調製し、水性原液69.6gとメチルパーフルオロブチルエーテル8.0gを乳化させた。次いで、この乳化物77.6gをアルミニウム製耐圧容器に充填し、容器の開口部にエアゾールバルブを固着した。さらにバルブから液化石油ガス(脂肪族炭化水素)2.4gを充填し、容器を上下に振って乳化させ、エアゾール組成物を製造した。得られたエアゾール組成物の評価結果を表1に示す。
Example 2 (face washing foam)
The following aqueous stock solution was prepared, and 69.6 g of the aqueous stock solution and 8.0 g of methyl perfluorobutyl ether were emulsified. Next, 77.6 g of this emulsion was filled in an aluminum pressure vessel, and an aerosol valve was fixed to the opening of the vessel. Further, 2.4 g of liquefied petroleum gas (aliphatic hydrocarbon) was filled from the valve and emulsified by shaking the container up and down to produce an aerosol composition. The evaluation results of the obtained aerosol composition are shown in Table 1.
<水性原液>
パルミチン酸(*5) 10.0
グリセリン(*6) 10.0
トリエタノールアミン 5.5
コカミドDEA(*7) 3.0
メチルパラベン 0.1
精製水 71.4
合計 100.0(重量%)
<Aqueous stock solution>
Palmitic acid (* 5) 10.0
Glycerin (* 6) 10.0
Triethanolamine 5.5
Cocamide DEA (* 7) 3.0
Methylparaben 0.1
Purified water 71.4
Total 100.0 (% by weight)
<エアゾール組成物>
上記水性原液 87.0
メチルパーフルオロブチルエーテル(*8) 10.0
液化石油ガス(*4) 3.0
合計 100.0(重量%)
*5:ルナックP−95(商品名)、花王(株)製
*6:濃グリセリン(商品名)、花王(株)製
*7:アミゾールCDE(商品名)、ヤシ脂肪酸ジエタノールアミド、川研ファインケミカル(株)製
*8:CF−61(商品名)、住友スリーエム(株)製
<Aerosol composition>
The above aqueous stock solution 87.0
Methyl perfluorobutyl ether (* 8) 10.0
Liquefied petroleum gas (* 4) 3.0
Total 100.0 (% by weight)
* 5: LUNAC P-95 (trade name), manufactured by Kao Corporation * 6: Concentrated glycerin (trade name), manufactured by Kao Corporation * 7: Amizole CDE (trade name), palm fatty acid diethanolamide, Kawaken Fine Chemical * 8: CF-61 (trade name), manufactured by Sumitomo 3M Limited
実施例3
実施例2の液化石油ガス(*4)の代わりに、20℃での蒸気圧が0.47MPaである液化石油ガス(*9)を用いた以外は実施例2と同様にしてエアゾール組成物を製造した。得られたエアゾール組成物の評価結果を表1に示す。
*9:20℃での蒸気圧が0.47MPa
プロパン:イソブタン:ノルマルブタン=50:12.5:37.5(重量比)
Example 3
An aerosol composition was prepared in the same manner as in Example 2 except that liquefied petroleum gas (* 9) having a vapor pressure at 20 ° C. of 0.47 MPa was used instead of liquefied petroleum gas (* 4) of Example 2. Manufactured. The evaluation results of the obtained aerosol composition are shown in Table 1.
* 9: Vapor pressure at 20 ° C is 0.47 MPa
Propane: isobutane: normal butane = 50: 12.5: 37.5 (weight ratio)
実施例4
実施例2の液化石油ガス(*4)の代わりに、20℃での蒸気圧が0.39MPaである液化石油ガス(*10)を用いた以外は実施例2と同様にしてエアゾール組成物を製造した。得られたエアゾール組成物の評価結果を表1に示す。
*10:20℃での蒸気圧が0.39MPa
プロパン:イソブタン:ノルマルブタン=35:16.2:48.8(重量比)
Example 4
An aerosol composition was prepared in the same manner as in Example 2 except that liquefied petroleum gas (* 10) having a vapor pressure of 0.39 MPa at 20 ° C. was used instead of liquefied petroleum gas (* 4) of Example 2. Manufactured. The evaluation results of the obtained aerosol composition are shown in Table 1.
* 10: Vapor pressure at 20 ° C is 0.39 MPa
Propane: isobutane: normal butane = 35: 16.2: 48.8 (weight ratio)
実施例5
実施例2の水性原液69.6g(87重量%)、メチルパーフルオロブチルエーテル2.4g(3重量%)、液化石油ガス(*4)8.0g(10重量%)を用いて、実施例2と同様にしてエアゾール組成物を製造した。得られたエアゾール組成物の評価結果を表1に示す。
Example 5
Example 2 using 69.6 g (87% by weight) of the aqueous stock solution of Example 2, 2.4 g (3% by weight) of methyl perfluorobutyl ether, and 8.0 g (10% by weight) of liquefied petroleum gas (* 4). In the same manner, an aerosol composition was produced. The evaluation results of the obtained aerosol composition are shown in Table 1.
比較例1
実施例2のメチルパーフルオロブチルエーテルの代わりにイソペンタン(脂肪族炭化水素、沸点27.9℃)を用いた以外は実施例2と同様にしてエアゾール組成物を製造した。得られたエアゾール組成物の評価結果を表1に示す。
Comparative Example 1
An aerosol composition was produced in the same manner as in Example 2 except that isopentane (aliphatic hydrocarbon, boiling point: 27.9 ° C.) was used instead of methyl perfluorobutyl ether in Example 2. The evaluation results of the obtained aerosol composition are shown in Table 1.
比較例2
実施例2の水性原液72.0g(90重量%)とメチルパーフルオロブチルエーテル8.0g(10重量%)とを乳化させた。次いで、この乳化物80gを二重エアゾール容器の内袋に充填し、外容器と内袋の間の空間に窒素ガスを充填し、容器の開口部にエアゾールバルブを固着した。得られたエアゾール組成物の評価結果を表1に示す。
Comparative Example 2
72.0 g (90% by weight) of the aqueous stock solution of Example 2 and 8.0 g (10% by weight) of methyl perfluorobutyl ether were emulsified. Next, 80 g of this emulsion was filled in the inner bag of the double aerosol container, nitrogen gas was filled in the space between the outer container and the inner bag, and an aerosol valve was fixed to the opening of the container. The evaluation results of the obtained aerosol composition are shown in Table 1.
比較例3
実施例2の水性原液76.0g(95重量%)をアルミニウム製耐圧容器に充填し、容器の開口部にエアゾールバルブを固着した。さらにバルブから液化石油ガス(*4)4.0g(5重量%)を充填し、容器を上下に振って乳化させ、エアゾール組成物を製造した。得られたエアゾール組成物の評価結果を表1に示す。
Comparative Example 3
76.0 g (95% by weight) of the aqueous stock solution of Example 2 was filled in an aluminum pressure resistant container, and an aerosol valve was fixed to the opening of the container. Further, 4.0 g (5% by weight) of liquefied petroleum gas (* 4) was filled from the valve, and the container was shaken up and down to emulsify to produce an aerosol composition. The evaluation results of the obtained aerosol composition are shown in Table 1.
Claims (4)
沸点が50〜80℃であるハイドロフルオロエーテル0.5〜20重量%、および
沸点が−50〜5℃である脂肪族炭化水素0.5〜10重量%
を含有する発泡性エアゾール組成物。 70-98% by weight of an aqueous stock solution containing a surfactant,
0.5-20% by weight of a hydrofluoroether having a boiling point of 50-80 ° C. and 0.5-10% by weight of an aliphatic hydrocarbon having a boiling point of −50-5 ° C.
A foamable aerosol composition comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007069251A JP2008230982A (en) | 2007-03-16 | 2007-03-16 | Foamable aerosol composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007069251A JP2008230982A (en) | 2007-03-16 | 2007-03-16 | Foamable aerosol composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2008230982A true JP2008230982A (en) | 2008-10-02 |
Family
ID=39904221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007069251A Pending JP2008230982A (en) | 2007-03-16 | 2007-03-16 | Foamable aerosol composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2008230982A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009269833A (en) * | 2008-05-01 | 2009-11-19 | Noevir Co Ltd | Skin external preparation |
JP2014051481A (en) * | 2012-09-07 | 2014-03-20 | Nobel Kagaku Kogyo Kk | Foamable topical agent |
JP2014088330A (en) * | 2012-10-29 | 2014-05-15 | Pola Chem Ind Inc | Foamy aerosol type skin external composition |
JP2018033349A (en) * | 2016-08-30 | 2018-03-08 | 学校法人神奈川大学 | Foamable emulsion composition, foamable composition, foamed substance, method for improving foamability, foamability improving agent, and method for adjusting solidity of foam |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02255889A (en) * | 1988-12-27 | 1990-10-16 | Osaka Aerosol Ind Corp | Aerosol composition |
JPH09124440A (en) * | 1995-10-26 | 1997-05-13 | Kanebo Ltd | Foamy cosmetic for skin or hair |
JP2001039841A (en) * | 1999-07-30 | 2001-02-13 | Daizo:Kk | Foaming composition for hair dressing |
JP2005519142A (en) * | 2001-11-20 | 2005-06-30 | エイボン プロダクツ インコーポレーテッド | Cosmetic composition with reproducible texture |
JP2006265137A (en) * | 2005-03-23 | 2006-10-05 | Daizo:Kk | Emulsion aerosol composition |
-
2007
- 2007-03-16 JP JP2007069251A patent/JP2008230982A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02255889A (en) * | 1988-12-27 | 1990-10-16 | Osaka Aerosol Ind Corp | Aerosol composition |
JPH09124440A (en) * | 1995-10-26 | 1997-05-13 | Kanebo Ltd | Foamy cosmetic for skin or hair |
JP2001039841A (en) * | 1999-07-30 | 2001-02-13 | Daizo:Kk | Foaming composition for hair dressing |
JP2005519142A (en) * | 2001-11-20 | 2005-06-30 | エイボン プロダクツ インコーポレーテッド | Cosmetic composition with reproducible texture |
JP2006265137A (en) * | 2005-03-23 | 2006-10-05 | Daizo:Kk | Emulsion aerosol composition |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009269833A (en) * | 2008-05-01 | 2009-11-19 | Noevir Co Ltd | Skin external preparation |
JP2014051481A (en) * | 2012-09-07 | 2014-03-20 | Nobel Kagaku Kogyo Kk | Foamable topical agent |
JP2014088330A (en) * | 2012-10-29 | 2014-05-15 | Pola Chem Ind Inc | Foamy aerosol type skin external composition |
JP2018033349A (en) * | 2016-08-30 | 2018-03-08 | 学校法人神奈川大学 | Foamable emulsion composition, foamable composition, foamed substance, method for improving foamability, foamability improving agent, and method for adjusting solidity of foam |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6204535B2 (en) | Aerosol composition | |
JP4173034B2 (en) | Aerosol composition | |
WO2011155630A1 (en) | Aerosol composition | |
JP3981289B2 (en) | Foamable aerosol composition | |
JP5661253B2 (en) | Aerosol composition | |
JP5192784B2 (en) | Aerosol product and discharge method thereof | |
JP5283389B2 (en) | Aerosol composition | |
JP2003252725A (en) | Foamable aerosol composition | |
JP4624175B2 (en) | Aerosol composition for gel spray | |
JP2008230982A (en) | Foamable aerosol composition | |
JP4971713B2 (en) | Aerosol composition and aerosol product comprising the aerosol composition | |
JP4722434B2 (en) | Foamable aerosol composition | |
JP5180601B2 (en) | Aerosol composition | |
JP2009249343A (en) | Aerosol composition | |
JPWO2002083321A1 (en) | Aerosol products | |
JP7294873B2 (en) | Post-foaming composition | |
JP5276781B2 (en) | Aerosol composition | |
JP2003081763A (en) | Aerosol composition and foamable aerosol product | |
WO2019188795A1 (en) | Gel cosmetic | |
JP2001302445A (en) | Aerosol products | |
US8173112B2 (en) | Emulsified composition for hair | |
JP3936289B2 (en) | Aerosol composition | |
JP5341397B2 (en) | Aerosol composition | |
JP5920777B2 (en) | Foamable aerosol composition | |
JP7108502B2 (en) | Effervescent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091210 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20100517 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110915 |
|
A131 | Notification of reasons for refusal |
Effective date: 20111025 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120515 |